CymaBay Therapeutics, Inc.
Simbolo: CBAY
NASDAQ
32.48
USDPrezzo di mercato oggi
-32.9591
Rapporto P/E
0.0000
Rapporto PEG
3.73B
Capitalizzazione MRK
- 0.00%
Rendimento DIV
CymaBay Therapeutics, Inc. Struttura manageriale
Informazioni sul management
Nome | Titolo |
---|---|
Mr. Harish Shantharam C.F.A. | Chief Financial Officer, Principal Accounting & Financial Officer |
Ms. Becki Filice | Senior Vice President of Portfolio & Product Leadership |
Mr. Paul T. Quinlan | General Counsel, Chief Compliance Officer & Corporate Secretary |
Dr. Charles A. McWherter Ph.D. | President of Research & Development and Chief Scientific Officer |
Dr. Robert L. Martin | Senior Vice President of Manufacturing & Nonclinical Development |
Ms. Klara A. Dickinson-Eason | Chief Regulatory & Quality Assurance Officer |
Mr. Patrick J. O'Mara | Senior Vice President of Business Development |
Mr. Ben Kozub | Head of Commercial |
Mr. Ken Boehm | Senior Vice President of Human Resources |
Mr. Sujal A. Shah | President, Chief Executive Officer & Director |
Azioni simili
Potresti essere interessato anche a:SRNE
Top management:
- Dr. Henry H. Ji P...
MRVI
Top management:
- Ms. Debra Hart
- Ms. Rebecca Buzzeo
- Dr. Kate E. Brode...
CMRA
Top management:
- Ms. Janice Marie ...
- Dr. David Soane ...
- Mr. Michael G. Ca...
GUBRA.CO
Top management:
- Ms. Margit Bloch ...
- Ms. Trine Nygaard...
- Mr. Kristoffer R...
T5O.DE
Top management:
- Dr. Mark-André F...
- Dr. Dirk Kaiser
- Dr. Bruno Rosen
HBC.OL
Top management:
- Dr. Crawford Lind...
- Mr. James Berger
- Ms. Angelika Flo...
6826.HK
Top management:
- Ms. Caixia Ren
- Ms. Min Tian
- Mr. Ming King Ch...
PPBT
Top management:
- Mr. Ido Morpurgo...
- Mr. Lior Fhima C...
- Dr. Michael Schi...